Theravance Biopharma Aktie
8,65
EUR
±0,00
EUR
±0,00
%
9,17
USD
-0,18
USD
-1,93
%
Werbung
Theravance Biopharma Aktie Analyse
16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung